Conformation and Glycosylation of A Megalin Fragment Correlate with Nephritogenicity in Heymann Nephritis

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2367-2373

  Tramontano, Alfonso ^a   Makker, Sudesh P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; EPITOPE; LECTIN; MEGALIN; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BACULOVIRUS; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GLOMERULONEPHRITIS; HEYMANN NEPHRITIS; IMMUNE COMPLEX DEPOSITION; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; PROTEINURIA; RAT; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 0842300356     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2367     Document Type: Article

References (39)

1. Heymann, W., D. Hackel. Harwood, J., S. Wilson, and J. Hunter. 1959. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc. Soc. Exp. Biol. Med. 100:660.
2. Alousi, M., R. Post, and W. Heymann. 1969. Experimental autoimmune nephrosis in rats: morphogenesis of the glomerular lesion: immunohistochemical and electron microscopic studies. Am. J. Pathol. 54:47.
3. Edgington, T. S., R. J. Glassock, and F. J. Dixon. 1967. Autologous immune complex pathogenesis of experimental allergic glomerulonephritis. Science 155:1432.
4. Makker, S., and A. Singh. 1982. Biochemical analysis of nephritogenic rat kidney tubular membrane fraction (FxIA). Fed. Proc. 41:1159.
5. Makker. S., and A. Singh. 1984. Characterization of the antigen (gp600) of Heymann nephritis. Lab. Invest. 50:287.
6. Kerjaschki, D., and M. G. Farquhar. 1982. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl. Acad. Sci. USA 79:5557.
7. Saito, A., S. Pietromonaco, A. K. Loo, and M. G. Farquhar. 1994. Complete cloning and sequencing of rat gp330/"megalin" a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 91:9725.
8. Raats, C. J., M. E. Luca, M. A., Bakker, A. Van Der Wal, P. Heeringa, H. Van Goor, J. Van Den Born, E. De Heer, and J. H. Berden. 1999. Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. J. Am. Soc. Nephrol. 10:1689.
9. Van Leer, E. H., P. Ronco, P. Verroust, A. M. van der Wal, P. J. Hoedemaeker, and E. De Heer. 1993. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis. Am. J. Pathol. 142:821.
10. Cybulsky, A. V., H. G. Rennke, I. D. Feintzeig, and D. J. Salant. 1986. Complement-induced glomerular epithelial cell injury: role of the membrane attack complex in rat membranous nephropathy. J. Clin. Invest. 77:1096.
11. Salant, D. J., S. Belok. M. P. Madaio, and W. G. Couser. 1980. A new role for complement in experimental membranous nephropathy in rats. J. Clin. Invest. 66:1339.
12. Salant. D. J., R. J. Quigg, and A. V. Cybulsky. 1989. Heymann nephritis: mechanisms of renal injury. Kidney Int. 35:976.
13. Makker, S. P. 1993. Analysis of glomeruli-eluted gp330 autoantibodies and of gp330 antigen of Heymann nephritis. J. Immunol. 15:6500.
14. Leenaerts, P. L., B. M. Hall, B. J. Van Damme, M. R. Daha, and Y. F. Vanrenterghem. 1995. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 47:1604.
15. Penny, M. J., R. A. Boyd, and B. M. Hall. 1997. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int. 51:1059.
16. Walters, G., H. Wu, and J. F. Knight. 2001. Glomerular T cells in Heymann nephritis. Clin. Exp. Immunol. 126:319.
17. Kerjaschki, D., and M. G. Farquhar. 1983. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J. Exp. Med. 157:667.
18. Zheng, G., D. R. Bachinsky, I. Stamenkovic, D. K. Strickland, D. Brown, G. Andres, and R. T. McCluskey. 1994. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpa 2MR, and the receptor-associated protein (RAP). J. Histochem. Cvtochem. 42:531.
19. Argraves, W. S. 2001. Members of the low density lipoprotein receptor family control diverse physiological processes. Front. Biosci. 6:D406.
20. Christensen, E. I., and H. Birn. 2002. Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell. Biol. 3:256.
21. Yamazaki, H., R. Ullrich, M. Exner, A. Saito, R. A. Orlando, D. Kerjaschki, and M. G. Farquhar. 1998. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J. Am. Soc. Nephrol. 9:1638.
22. Orlando, R. A., D. Kerjaschki, H. Kurihara, D. Biemesderfer, and M. G. Farquhar. 1992. Gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc. Natl. Acad. Sci. USA 89:6698.
23. Kanalas, J. J., and S. P. Makker. 1993. Analysis of a 45-kDa protein that binds to the Heymann nephritis autoantigen GP330. J. Biol. Chem. 268:8188.
24. Huang, J., and S. P. Makker. 1995. Role of receptor-associated 39-45 kDa protein in active Heymann nephritis. Kidney Int. 47:432.
25. Raychowdhury, R., G. Zheng, D. Brown, and R. T. McCluskey. 1996. Induction of Heymann nephritis with a gp330/megalin fusion protein. Am. J. Pathol. 148:1613.
26. Huang, J., and S. P. Makker. 1997. Gp600/330 contains at least two autoimmunogenic forms that can induce active Heymann nephritis. J. Am. Soc. Nephrol. 8:457.
27. Oleinikov, A. V., B. J. Feliz, and S. P. Makker. 2000. A small N-terminal 60-kD fragment of gp600 (megalin) the major autoantigen of active Heymann nephritis can induce a full-blown disease. J. Am. Soc. Nephrol. 11:57.
28. Makker, S. P., R. Widstrom, and J. Huang. 1995. Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am. J. Pathol. 146:1481.
29. Jarvis, D. L., and E. E. Finn. 1995. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 212:500.
30. Ziak, M., D. Kerjaschki, M. G. Farquhar, and J. Roth. 1999. Identification of megalin as the sole rat kidney sialoglycoprotein containing poly α2. 8 deaminoneuraminic acid. J. Am. Soc. Nephrol. 10:203.
31. Raychowdhury, R., J. Niles, R. McCluskey, and J. Smith. 1989. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 244:1163.
32. Orlando, R. A., D. Kerjaschki, and M. G. Farquhar. 1995. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein. J. Am. Soc. Nephrol. 6:61.
33. Pietromonaco, S., D. Kerjaschki, S. Binder, R. Ullrich, and M. G. Farquhar. 1990. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc. Natl. Acad. Sci. USA 87:1811.
34. Kerjaschki, D., R. Ullrich, K. Diem, S. Pietromonaco, R. A. Orlando, and M. G. Farquhar. 1992. Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc. Natl. Acad. Sci. USA 89:11179.
35. Makker, S. 1980. Evidence that the antigen of autologous immune complex glomerulonephritis of rats is a mannose or glucose containing glycoprotein. Proc. Soc. Exp. Biol. Med. 163:95.
36. Doyle, H. A., and M. J. Mamula. 2001. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22:443.
37. Chui, D., G. Sellakumar, R. Green, M. Sutton-Smith, T. McQuistan, K. Marek, H. Morris, A. Dell, and J. Marth. 2001. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc. Natl. Acad. Sci. USA 98:1142.
38. Barchan, D., M. C. Souroujon, S. H. Im, C. Antozzi, and S. Fuchs. 1999. Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor a-subunit. Proc. Natl. Acad. Sci. USA 96:8086.
39. Im, S. H., D. Barchan, M. C. Souroujon, and S. Fuchs. 2000. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. J. Immunol. 165:3599.